MedTrace Logo

CISCO-21 Prevent and Treat Long COVID-19.

NCT04900961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2025-02-25

No results posted yet for this study

Summary

Many people have long-lasting symptoms after COVID-19, such as breathlessness, fatigue and chest pain. So far, research studies of treatments for COVID-19 have focused on the life-threatening acute illness; few studies look at treatments to improve long-term health after COVID-19. COVID-19, particularly when this requires a hospital admission, can lead to weight loss and muscle wasting, contributing to worse outcomes. Muscle strengthening (resistance-based) exercise could improve outcomes in the long-term.

Conditions

  • Covid19

Interventions

OTHER

Resistance Exercise

The exercise regimens are generic and designed not to require expert physiotherapy input, therefore, the availability of NHS physiotherapists, which may be at times limited, will not be a barrier to implementation

Sponsors & Collaborators

  • University of Glasgow

    collaborator OTHER

  • Chief Scientist Office of the Scottish Government

    collaborator OTHER_GOV

  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • Colin Berry, BSc MBChB PhD · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2024-08-30
Completion
2025-02-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04900961 on ClinicalTrials.gov